LETHAL HANTAVIURS with 30% fatality rate now AEROSOLIZED by U.S. military and set for release for next PLANDEMIC
By sdwells // 2025-09-23
Copy
 
A July study published in Pathogens and funded by the Defense Threat Reduction Agency (DTRA) describes experiments in which scientists deliberately aerosolized Sin Nombre virus (SNV), a hantavirus with an estimated ~30% fatality rate, to study how long the virus remains infectious in air under varying environmental conditions. The work, conducted at the University of Nebraska Medical Center (UNMC) using a Biological Aerosol Reaction Chamber (Bio-ARC), has sparked alarm because aerosolization is a core step in converting a pathogen into a respiratory hazard—and because the research was financed by a Pentagon agency.
  • DTRA-funded aerosol study of a lethal hantavirus: A July paper in Pathogens reports researchers deliberately aerosolized Sin Nombre virus (SNV)—a rodent-borne hantavirus with ~30% fatality and no approved vaccine or treatment—under a Defense Threat Reduction Agency grant.
  • Aerosolization and airborne stability measured: Using a 120 kHz ultrasonic nozzle and the Bio-ARC system at UNMC, scientists produced submicron and ~1–2 µm particles and tracked how long SNV remained infectious under controlled humidity, ozone, and simulated sunlight conditions.
  • Dual-use and safety concerns: Although framed as “biodefense” (to understand SNV decay and prevention), the experiments involve the same technical steps (stabilizing aerosols, lung-penetrating particle sizes) that could enable weaponization or pose accidental-release risks, prompting alarm from critics.
  • Who did the work and why people worry: The team (UNMC, NSRI, UNM authors named in the paper) conclude the research informs prevention, but opponents argue taxpayer-funded studies that probe aerosol stability of lethal pathogens demand stricter oversight because they blur defense vs. offensive research.

U.S. Military Aerosolizes Hantavirus with 30% Fatality Rate in Nebraska: Journal Pathogens

Researchers converted liquid suspensions of SNV into airborne particles using an ultrasonic nozzle and carrier air, producing a bimodal particle-size distribution with peaks under one micron and under two microns—sizes that can penetrate deep into human lungs. The team then monitored viral decay across controlled conditions: humidity, simulated sunlight, and the presence of ozone. At roughly 49% relative humidity, introducing 1.0 ppm ozone markedly increased viral decay, while sunlight weakened but did not completely eliminate infectivity. The authors report that SNV can persist airborne long enough under some conditions to pose an environmental risk indoors—precisely the settings (barns, sheds, attics) where rodent-to-human transmission is often observed. The study frames the work as biodefense—designed to “gain insight into the SNV bioaerosol decay profile” to prevent infections—but critics argue the experiments blur the line between defensive research and knowledge that could be misused to weaponize a pathogen. The paper’s methodology—turning a high-fatality, rodent-borne virus into respirable particles and characterizing survival—mirrors technical steps essential to developing a respiratory agent. Observers point to the combination of federal funding, the lethal nature of SNV, and the generation of precise stability and particle-size data as troubling. Authors compared SNV’s environmental transmission characteristics to other viruses with airborne or environmental transmission potential, including avian influenza and Lassa virus, underscoring concerns about pandemic risk should SNV acquire person-to-person transmissibility akin to Andes virus in South America. The absence of licensed treatments or vaccines for SNV increases the stakes: a virus with ~30% mortality and optimized for airborne delivery would present a dire public-health challenge. Institutional affiliations include UNMC departments, the Global Center for Health Security, the National Strategic Research Institute (NSRI), and the University of New Mexico’s Center for Global Health. The author list names multiple researchers involved in aerosol generation, environmental simulation, and virological assays. Supporters of the research argue that understanding how SNV behaves in air is crucial for protecting agricultural workers, first responders, and communities at risk of hantavirus exposure. They contend that controlled laboratory studies inform mitigation—ventilation, disinfection, and decontamination measures—that can reduce natural spillover infections. Detractors, meanwhile, see the study as emblematic of a pattern where taxpayer-funded projects produce detailed, dual-use data with potential to inform both defense and offense. The debate raises central questions about oversight, transparency, and where biodefense ends and risky experimentation begins. In short: the paper documents that a high-fatality hantavirus can be aerosolized into lung-penetrating particles and remain infectious under certain indoor conditions—a finding that both informs public-health defenses and fuels ethical and security concerns about the collection and funding of such knowledge. Bookmark plague.info to your favorite independent websites for updates on new aerosolized gain-of-function viruses the military, NIH, CDC and WHO plan to release into the “wild” while blaming infected bat soup eaters at the Wuhan wet market. Sources for this article include: Pandemic.news GatewayPundit.com NaturalNews.com JonFleetwood.substack.com        
Copy